These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9032323)

  • 1. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.
    Cantin R; Fortin JF; Lamontagne G; Tremblay M
    J Virol; 1997 Mar; 71(3):1922-30. PubMed ID: 9032323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells.
    Cantin R; Fortin JF; Lamontagne G; Tremblay M
    Blood; 1997 Aug; 90(3):1091-100. PubMed ID: 9242540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific.
    Cantin R; Fortin JF; Tremblay M
    Virology; 1996 Apr; 218(2):372-81. PubMed ID: 8610464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.
    Fortin JF; Cantin R; Tremblay MJ
    J Virol; 1998 Mar; 72(3):2105-12. PubMed ID: 9499066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.
    Cosma A; Blanc D; Braun J; Quillent C; Barassi C; Moog C; Klasen S; Spire B; Scarlatti G; Pesenti E; Siccardi AG; Beretta A
    AIDS; 1999 Oct; 13(15):2033-42. PubMed ID: 10546855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
    Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
    Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1.
    Giguère JF; Paquette JS; Bounou S; Cantin R; Tremblay MJ
    J Immunol; 2002 Sep; 169(5):2762-71. PubMed ID: 12193751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source.
    Cantin R; Martin G; Tremblay MJ
    J Gen Virol; 2001 Dec; 82(Pt 12):2979-2987. PubMed ID: 11714974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
    Martin G; Beauséjour Y; Thibodeau J; Tremblay MJ
    Virology; 2005 May; 335(2):286-90. PubMed ID: 15840527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
    Rossio JL; Esser MT; Suryanarayana K; Schneider DK; Bess JW; Vasquez GM; Wiltrout TA; Chertova E; Grimes MK; Sattentau Q; Arthur LO; Henderson LE; Lifson JD
    J Virol; 1998 Oct; 72(10):7992-8001. PubMed ID: 9733838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.
    Paquette JS; Fortin JF; Blanchard L; Tremblay MJ
    J Virol; 1998 Nov; 72(11):9329-36. PubMed ID: 9765484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    Pandori MW; Fitch NJ; Craig HM; Richman DD; Spina CA; Guatelli JC
    J Virol; 1996 Jul; 70(7):4283-90. PubMed ID: 8676450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virion-targeted viral inactivation: new therapy against viral infection.
    Okui N; Kitamura Y; Kobayashi N; Sakuma R; Ishikawa T; Kitamura T
    Mol Urol; 2001; 5(2):59-66. PubMed ID: 11690549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.
    Meerloo T; Sheikh MA; Bloem AC; de Ronde A; Schutten M; van Els CA; Roholl PJ; Joling P; Goudsmit J; Schuurman HJ
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():129-35. PubMed ID: 8093711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel allo-independent HIV-1 virus preparation for use in immunoassays.
    Koesters S; Rutherford W; Fowke KR
    J Immunol Methods; 2002 Jun; 264(1-2):69-76. PubMed ID: 12191511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells.
    Castilletti C; Capobianchi MR; Fais S; Abbate I; Ficociello B; Ameglio F; Cordiali Fei P; Santini SM; Dianzani F
    AIDS Res Hum Retroviruses; 1995 May; 11(5):547-53. PubMed ID: 7576910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
    Bounou S; Leclerc JE; Tremblay MJ
    J Virol; 2002 Feb; 76(3):1004-14. PubMed ID: 11773376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
    Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
    J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.